Abstract
Antigen-specific tolerance is the ultimate aim of treatment of allergic diseases. Here, we describe methods for the use of biodegradable nanoparticles to safely induce tolerance for the prevention and treatment of allergic inflammation in mice. Antigen is either conjugated to the surface of carboxylated poly(lactide-co-glycolide) (PLG) or encapsulated within PLG nanoparticles, and the resulting antigen-associated nanoparticles are then washed prior to intravenous injection to inhibit antigen-specific allergic immune responses.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Smarr CB, Bryce PJ, Miller SD (2013) Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases. Crit Rev Immunol 33(5):389–414
Getts DR, Turley DM, Smith CE, Harp CT, McCarthy D, Feeney EM, Getts MT, Martin AJ, Luo X, Terry RL, King NJ, Miller SD (2011) Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells. J Immunol 187(5):2405–2417. https://doi.org/10.4049/jimmunol.1004175
Prasad S, Kohm AP, McMahon JS, Luo X, Miller SD (2012) Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading. J Autoimmun 39(4):347–353. https://doi.org/10.1016/j.jaut.2012.04.005
Smarr CB, Hsu CL, Byrne AJ, Miller SD, Bryce PJ (2011) Antigen-fixed leukocytes tolerize Th2 responses in mouse models of allergy. J Immunol 187(10):5090–5098. https://doi.org/10.4049/jimmunol.1100608
Clemente-Casares X, Blanco J, Ambalavanan P, Yamanouchi J, Singha S, Fandos C, Tsai S, Wang J, Garabatos N, Izquierdo C, Agrawal S, Keough MB, Yong VW, James E, Moore A, Yang Y, Stratmann T, Serra P, Santamaria P (2016) Expanding antigen-specific regulatory networks to treat autoimmunity. Nature 530(7591):434–440. https://doi.org/10.1038/nature16962
Getts DR, Martin AJ, McCarthy DP, Terry RL, Hunter ZN, Yap WT, Ge tts MT, Pleiss M, Luo X, King NJ, Shea LD, Miller SD (2012) Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nat Biotechnol 30(12):1217–1224. https://doi.org/10.1038/nbt.2434
Hunter Z, McCarthy DP, Yap WT, Harp CT, Getts DR, Shea LD, Miller SD (2014) A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease. ACS Nano 8(3):2148–2160. https://doi.org/10.1021/nn405033r
McCarthy DP, Yap JW, Harp CT, Song WK, Chen J, Pearson RM, Miller SD, Shea LD (2017) An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy. Nanomedicine 13(1):191–200. https://doi.org/10.1016/j.nano.2016.09.007
Smarr CB, Yap WT, Neef TP, Pearson RM, Hunter ZN, Ifergan I, Getts DR, Bryce PJ, Shea LD, Miller SD (2016) Biodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization. Proc Natl Acad Sci U S A 113(18):5059–5064. https://doi.org/10.1073/pnas.1505782113
Yap WT, Song WK, Chauhan N, Scalise PN, Agarwal R, Miller SD, Shea LD (2014) Quantification of particle-conjugated or particle-encapsulated peptides on interfering reagent backgrounds. Biotechniques 57(1):39–44. https://doi.org/10.2144/000114190
Acknowledgments
This study was supported by NIH Grant EB013198 and Juvenile Diabetes Research Society Grant 2-SRA-2014-279-Q-R.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Smarr, C.B., Miller, S.D. (2018). The Use of Biodegradable Nanoparticles for Tolerogenic Therapy of Allergic Inflammation. In: Reinhardt, R. (eds) Type 2 Immunity. Methods in Molecular Biology, vol 1799. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-7896-0_25
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7896-0_25
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-7895-3
Online ISBN: 978-1-4939-7896-0
eBook Packages: Springer Protocols